Do you test ovarian cancer tumors for targetable biomarkers (e.g., HER2, folate receptor, MMR) at the time of primary diagnosis or at time of recurrence?

When do you test ovarian cancer for targetable biomarkers (folate receptor, HER2, etc.)?

• At time of primary diagnosis
• At time of first recurrence
• Once deemed platinum-resistant
• Other